Anthony Letai, Director of the National Cancer Institute, shared on X:
“More than half of cancer deaths are preventable. National Cancer Institute is committed to advancing prevention research, and I’ve appointed Dr. Phil Castle as the Associate Director for Prevention to coordinate efforts to find, test, and apply ways to prevent cancer.”
About Dr. Philip E. Castle
Dr. Philip E. Castle is an internationally recognized expert in cervical cancer prevention. His research on HPV vaccination, screening regimens, and the natural history of cervical precancer has informed U.S. screening guidelines, including the adoption of primary HPV testing. He has also helped develop and validate new HPV tests, many of them FDA-approved.
He first joined NCI in 2000 as a Cancer Prevention Fellow, and was tenured in 2010. He then led ASCCP as Executive Director and later Chief Scientific Officer, served as a professor at Albert Einstein College of Medicine, and co-founded the Global Coalition Against Cervical Cancer. He returned to NCI in 2021 and is Director of the Division of Cancer Prevention. His current work includes HPV vaccine effectiveness in women living with HIV, and global health projects on breast cancer triage in low-resource settings and oral cavity cancer prevention.
You can also read:
Julio Aguirre-Ghiso: $10 Million NCI Grant to Investigate Early Breast Cancer Spread and Recurrence